R Squared Ltd acquired a new stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission.
with a drug now in Phase 2 to treat the fibrosis element of Alström Syndrome as a result of such interaction. GlobalData’s analysis ultimately says that orphan drugs face an “uphill battle ...
After hours: January 31 at 4:08:56 PM EST Loading Chart for RYTM ...
After hours: 31 January at 4:08:56 pm GMT-5 ...